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Hemodynamic changes during sequential ultrafiltration and
dialysis. Seven patients on regular dialysis were studied to eluci-
date the hemodynamic changes during ultrafiltration and dial-
ysis, performed sequentially, the period of ultrafiltration (1 hour)
either preceding or following dialysis (3 hours). During dialysis,
ultrafiltration was prevented by applying positive pressure in the
dialysate compartment. Cardiac index (dye dilution: indocyanine
green), heart rate, stroke volume index, blood pressure,
and total peripheral vascular resistance index were mea-
sured. During ultrafiltration, cardiac index and stroke volume in-
dex decreased, but heart rate was not significantly changed.
Total peripheral vascular resistance increased, resulting in un-
changed blood pressure. During dialysis, the total peripheral vas-
cular resistance decreased, but cardiac index and heart rate in-
creased. BP decreased when the increase in cardiac index was
insufficient to compensate for the decrease in total peripheral
vascular resistance. PRA increased during ultrafiltration due to
hypovolemia and decreased during dialysis, presumably due to
decreased sympathetic activity which may also be a cause of
dialysis-induced vasodilation.
Modifications hémodynamiques au cours de I'ultrafiltration et
de Ia dialyse sequentielles. Sept malades soumis reguhierement a
la dialyse ont été étudiés afin d'analyser les modifications hémo-
dynamiques au cours de l'ultrafiltration et de Ia dialyse réalisées
séquentiellement. La periode d'ultrafiltration (1 heure) a soit
précédé soit suivi celle de La dialyse (3 heures). Au cours de Ia
dialyse l'ultrafiltration a été éliminée par l'application d'une
pression positive au compartiment contenant le dialysat. L'index
cardiaque (dilution de colorant:indocyanine veil), le rhythme
cardiaque, l'index d'éjection, Ia pression sanguine et Ia résis-
tance vasculaire périphérique totale ont été mesurés. Au cours
de I'ultrafiltration I'index cardiaque et le volume d'éjection di-
minuent, mais le rythme cardiaque n'est pas significativement
modiflé. La résistance vasculaire périphérique totale augmente,
ce qui a pour résultat l'absence de modification de Ia pression
sanguine. Au cours de Ia dialyse Ia résistance vasculaire périphé-
rique totale diminue, alors que l'index et le rythme cardiaques
augmentent. La pression sanguine diminue quand l'augmen-
tation de l'index cardiaque est insuffisante pour compenser
la diminution de Ia résistance vasculaire péripherique totale.
L'activité refine plasmatique augmente au cours de l'ultra-
filtration du fait de l'hypovolémie et diminue durant Ia dial-
yse, probablement du fait de la diminution de I'activité sympa-
thique qui peut aussi être une cause de vasodilatation induite par
Ia dialyse.
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During the last few years, short-time dialysis (3 to
4 hours three times a week or every other day) has
proven to be successful in the treatment of patients
with chronic uremia [1]. A limiting factor in reduc-
ing dialysis time, however, is the inability to com-
fortably remove excess water and sodium in a very
short time. One reason for this is that rapid ultrafil-
tration during dialysis often leads to arterial hypo-
tension, assumed to be caused by hypovolemia [2].
We have shown earlier that more rapid ultrafiltra-
tion can be tolerated without reducing blood pres-
sure (BP), when performed without simultaneous
dialysis, than when combined with dialysis [3], sug-
gesting that solute shifts induced by dialysis inter-
fere with BP control, thus contributing to hypoten-
sion. We also observed that dialysis without simul-
taneous ultrafiltration may cause a fall in BP [4],
suggesting that the dialysis itself has a hypotensive
effect.
A few hemodynamic studies have been made dur-
ing hemodialysis, but no uniform results have been
obtained; cardiac output has been reported to be in-
creased [5], unchanged [6], or decreased [7, 8] dur-
ing or after dialysis. One explanation may be that
conventional hemodialysis combines ultrafiltration
and dialysis, that is, two processes which may have
different hemodynamic effects.
In the present study made in patients with cardio-
vascular instability and in one binephrectomized
patient, ultrafiltration and dialysis were separated in
time and performed sequentially, the period of ul-
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trafiltration either preceding or following dialysis.
The effect of each procedure on BP, cardiac output,
peripheral vascular resistance, and plasma renin ac-
tivity (PRA) were investigated.
Preliminary reports of this study have been given
earlier [9, 10].
Methods
Seven regular dialysis patients, aged 34 to 78
years, were studied after informed consent had
been obtained. They all had end-stage renal failure
with creatinine clearances less than 1.5 mI/mm; one
patient (patient 3) was binephrectomized (Table 1).
All except patient 3 had frequent episodes of hypo-
tension during conventional dialysis. Four patients
had compensated cardiac failure and were treated
with digoxin, and one of them had atrial fibrillation
at the time of investigation. Two patients were
treated with hydralazine, which was not given on
the day of investigation. All patients were studied
according to two different protocols, where ultrafil-
tration and dialysis were separated and performed
sequentially.
Procedure 1. Ultrafiltration was performed for 1
hour, followed by dialysis for 3 hours.
Procedure 2. Dialysis was performed for 3 hours,
followed by ultrafiltration for 1 hour.
During ultrafiltration, in both procedures, it was
aimed at reducing the body weight to an empirically
estimated dry weight. Procedures I and 2 were gen-
erally performed within a 1-week interval.
Polyacrylonitrile parallel flow dialyzers (RhOne-
Poulenc RP-6), 1.03 m2, were used together with a
Gambro Ultradiffusion Monitor (UDM), which en-
ables ultrafiltration and dialysis to be performed
separately. The function of UDM was described
earlier in detail [11, 12]. The rate of ultrafiltration
was directly determined by collecting the ultrafil-
trate in a measuring cylinder. During dialysis, a pos-
itive hydrostatic pressure was created in the dialy-
sate compartment, which counterbalanced the pres-
sure in the blood compartment, allowing the body
weight to be kept within 50 g. The dialysate was
prepared in a tank by weighing water and salts im-
mediately prior to each procedure; thus, the propor-
tioning system of UDM was not used.
The dialysate had the following composition, in
mmoles per liter: sodium, 140; potassium, 2.5; cal-
cium, 1.75; magnesium, 0.50; acetate, 40.0; and
chloride, 107.
Blood access was obtained by s.c. arteriovenous
fistulae in six patients and by a Scribner shunt in
one patient (patient 2). Blood flow was maintained
at 200 ml/min by a precalibrated blood pump and
was continuously monitored by a Ward ultrasonic
flow meter.
A loading dose of heparin was given i.v. (5000 to
7500 IU) followed by a continuous infusion of hepa-
nfl from a syringe pump (500 to 750 IUIhr).
The blood compartment of the dialyzer was
primed with 0.9% saline. The blood lines were con-
nected to the fistula needles or shunt tubings with-
out discarding the priming saline, and the blood was
circulated through the dialyzer for at least 15 mm
without any ultrafiltration and with no dialysate
passing through the dialyzer (recirculation 1). After
the initial period of ultrafiltration or dialysis, re-
spectively, the blood was again recirculated for 15
miii (recirculation 2) before the continuation of the
study.
Systolic and diastolic BP and heart rate were
measured and registered every 5 mm, with an Arte-
riosonde ultrasonic noninvasive blood pressure ma-
nometer (Roche) and a single electrode pulse meter
(Kontron). Body weight changes were continuously
measured with a metabolic bed scale (Datex, Gam-
Table. 1. Clinical data
Patient Age Weight Height Basal BP Heart volume
no. Diagnosis yr Sex kg cm mm Hg mi/rn2 (x-ray) Drug therapy
I Nephrosclerosis 61 F 68.5 161 120/65 560 Digoxin
2 Glomerulonephritis, 78 M 71.5 177 160/95 730 Digoxin
atrial fibrillation Verpamil
3 Ulomerulonephritis, 37 F 52.0 164 105/65 390 —
bilat. nephrectomy
4 Nephrosclerosis 63 M 69.0 174 210/105 700 Digoxin
Furosemide
Hydralazine
5 Glomerulonephritis 34 F 52.5 165 140/90 430 —
6 Pyelonephritis, 56 F 48.5 153 125/45 630 Digoxin
aortic insufficiency
7 Polycystic kidney 56 F 49.0 165 180/95 590 Hydralazine
disease
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bro) connected to an Omni Scribe recorder. Dupli-
cate determinations of cardiac output were made
during each recirculation period, and single deter-
minations were made after 30 and 60 mm of ultrafil-
tration and after 60, 120, and 180 mm of dialysis.
Cardiac output was measured with a dye dilution
technique, with indocyanine green (Cardio-green®,
Hynson, Westcott & Dunning, Inc.) similar to the
technique described by Charra et a! [13]. The same
blood accesses were used as for dialysis. One fistula
needle was inserted near the fistula anastomosis,
and the other needle was placed as proximally as
possible. For each determination, 10 mg of dye in 2
ml of distilled water was rapidly injected with a cali-
brated syringe into the venous blood line connected
to the proximal needle, immediately followed by
flushing with 10 ml of saline. Blood was drawn from
the arterial blood line (connected to the distal
needle) through a Beckman cardiodensitometer
(LKB-Beckman Instruments AB) with a withdrawal
pump (syringe pump model 531, Sage Instruments
Inc.) with a speed of 30 ml/min. After the recording,
the blood withdrawn was reinjected to the patient.
Calibration was made by adding 100 ii of the di-
luted dye to 50 ml of the patient's blood in a sterile
syringe; after thorough mixing, this blood was
drawn through the densitometer, then reinfused to
the patient. Two calibrations were performed dur-
ing and at the end of each study. Evidence of local
recirculation of dye in the fistula was seen in only
one patient and was easily prevented with gentle ex-
ternal pressure on the blood vessel between the
proximal and distal needle during injection of the
dye.
The BP values presented in the results were ob-
tained immediately before the cardiac output deter-
mination. Mean arterial BP was calculated as dis-
tolic pressure + one third of the pulse pressure.
Cardiac index and stroke volume index were calcu-
lated by dividing cardiac output and stroke volume
with the body surface area. Total peripheral vascu-
lar resistance index was calculated by dividing
mean arterial pressure by cardiac index and was ex-
pressed in arbitrary units.
Heparinized blood samples were obtained from
the arterial blood line before, after recirculation 1,
and after each period of ultrafiltration and dialysis.
Sodium and potassium (flame photometry), urea
(urease/GLDH), creatinine (kinetic procedure [14]),
and glucose (glucose oxidase [15]) were analyzed
with an IL 919 analyzer and an IL 743 Digital flame
photometer attached to an IL 463 printer/sampler
system to provide automatic sampling and record-
ing. Osmolality of plasma and of dialysate was mea-
sured with a 5100 vapor pressure osmometer (Wes-
cor, Inc.), which determines osmolality by sensing
the vapor pressure above the solution in a closed
chamber. The sample volumes were 5 il and the
precision 3 mOsmlkg.
PRA was measured in five nonnephrectomized
patients, with a radioimmunologic method (NEN
commercial kit).
Statistical analyses of changes were made by Stu-
dent's paired t test, comparing the values during the
ultrafiltration and dialysis, respectively, with the
values obtained before or during the preceding re-
circulation periods.
Results
Body weight. The body weight decreased during
ultrafiltration in procedure 1 by 1.85 0.14 kg
(mean 5EM) and in procedure 2 by 1.73 0.21 kg.
During dialysis, the body weight was kept constant
(procedure 1, +0.005 0.006 kg; procedure 2,
+0.0025 0.0014 kg).
The mean values and standard errors of the he-
modynamic variables during procedures 1 and 2 are
given in Tables 2 and 3, respectively.
Blood pressure. Varying BP responses were ob-
served during ultrafiltration (Fig. 1); the mean val-
ues were not significantly changed. BP decreased
more often and more markedly during dialysis than
during ultrafiltration (Fig. I). Some cases, however,
showed stable BP during dialysis. Significant de-
creases in systolic, diastolic, and mean BPs (P <
0.05) were seen in procedure 1, and a significant de-
crease in diastolic BP was seen (P < 0.05) in proce-
dure 2.
Heart rate (Fig. 2). The heart rate increased sig-
nificantly during dialysis in both procedures. During
ultrafiltration, the heart rate showed increases as
well as decreases, but the mean value was not sig-
nificantly changed; thus, the increased heart rate af-
ter dialysis in procedure 2 remained high during the
following ultrafiltration period.
Cardiac index (Fig. 3). In procedure 1, cardiac
index decreased during ultrafiltration and increased
during dialysis, though not to the basal value. In
procedure 2, cardiac index increased significantly
above the basal value during dialysis but decreased
below the basal value after 30 mm's ultrafiltration
(P < 0.05).
Stroke volume index (Fig. 4). In the two proce-
dures, the stroke volume index decreased during ul-
trafiltration, but it was unchanged during dialysis.
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Table 2. Mean values, standard errors, and statistical evaluation of BP and hemodynamic variables in procedure 1 (ultrafiltration
followed by dialysis)
Recirculation 1
Ultrafiltration
30 mm 60 mm Recirculation 2
Dialysis
60 mm 120 mm 180 mm
(N=7) (N=7) (N=6) (N=7) (N=7) (N=7) (N=7)
Systolic arterial pressure, 148.0 143.0 151.0 145.0 130.Oa 130.Oa 130.0
mm Hg ±15.7 ±19.0 ±21.2 ±17.9 ±16.6 ±13.9 ±13.4
Diastolic arterial pressure, 78.0 80.0 86.0 80.0 75.0 72.0 71.0
mm Hg ± 8.3 ±10.5 ±11.3 ±10.7 ±11.1 ± 8.9 ± 9.0
Mean arterial pressure, 101.0 101.0 108.0 102.0 94.0 91.Oa 91,0
mm Hg ±10.5 ±12.8 ±14.4 ±12.5 ±12.2 ±10.1 ±10.0
Heart rate, 81.0 81.0 83.0 80.0 89.Oe %0bJ 980b.e
beats/mm ± 4.4 ± 3.2 ± 2.2 ± 2.2 ± 2.9 ± 2.8 ± 2.7
Cardiac index, 4.20 3.07" 271b 295b 333a 336 3,61a,d
liter/minim2 body surface ± 0.37 ± 0.30 ± 0.34 ± 0.27 ± 0.36 ± 0.43 ± 0.40
Stroke volume index, 52.0 38.Oa 33.0" 37.0" 37.0" 35.0 37.0"
mi/rn2 body surface ± 3.5 ± 3.2 ± 4.2 ± 3.2 ± 3.5 ± 3.8 ± 3.3
Total peripheral vascular 25.2 35,Øa 43.O' 36.6" 296d 29.6e 26.8
resistance index, U ± 3.4 ± 6.3 ± 9.6 ± 6.7 ± 4.9 ± 5.1 ± 4.1
a 0.01 <P < 0.05; " 0.001 <P < 0.01; P < 0.001 by paired t test, comparing the values with recirculation-1 values.
d 0.01 <P < 0.05; 0.00! < P < 0,01; 'P < 0.001 by paired t test, comparing the values with recirculation-2 values.
Thus, it remained decreased during dialysis follow-
ing ultrafiltration in procedure 1.
Total peripheral vascular resistance index (Fig.
5). This increased during ultrafiltration and de-
creased during dialysis. In procedure 1, the total pe-
ripheral vascular resistance index increased above
the basal value during ultrafiltration (P <0.05) and
decreased below the basal value during dialysis. In
procedure 2, it decreased significantly during dial-
ysis (P < 0,01) and increased during the following
ultrafiltration period.
Plasma renin activity (Fig. 6). Figure 6 presents
values obtained during the initial period of each pro-
cedure, that is, the effect of either initial ultrafiltra-
tion or initial dialysis. Ultrafiltration resulted in an
increase in PRA, whereas dialysis had the opposite
effect. After an initial period of either ultrafiltration
and dialysis, no consistent changes in PRA were ob-
served during the following period, presumably due
to carry-over effects from one period to the other.
Effect of ultrafiltration and dialysis on plasma
variables (Table 4). Osmolality, urea, and potas-
sium concentrations decreased during dialysis but
were unchanged during ultrafiltration in both proce-
dures. No significant changes were found in pH, so-
dium, and bicarbonate in either of the two proce-
dures.
Hematocrit and plasma protein decreased during
Table 3. Mean values, standard errors, and statistical evaluation of blood pressure and hemodynamic variables in procedure 2 (dialysis
followed by ultrafiltration)
Recirculation 1
(N=7)
60 mm
(N=7)
Dialysis
120 mm
(N=7)
180 mm
(N=6)
Recirculation 2
(N=7)
Ultrafil
30 mm
(N=7)
tration
60 mm
(N=4)
Systolic arterial pressure, 155.0 153.0 147.0 140.0 145.0 138.0 145.0
mm Hg ± 13.2 ± 9.7 ± 9.8 ± 8.0 ± 8.8 ±11.5 ± 18.2
Diastolic arterial pressure, 83.0 80.0" 76.Oa 74.Oa 76.0" 78.0 83.0
mm Hg ± 8.3 ± 7.9 ± 6.7 ± 9.6 ± 7.4 ± 9.4 ± 9.4
Mean arterial pressure, 107.0 104.0 100.0 96.0 99.0 98.0 103.0
mm Hg ± 9.2 ± 8.0 ± 7.5 ± 8.8 ± 7.6 ± 9.7 ±11.7
Heart rate 84.0 89.Oa 930 95.Ob 980b 960" 95.0
beats/mm ± 6.4 ± 5.6 ± 5.7 ± 6.7 ± 6.1 ± 6.2 ± 9.3
Cardiac index, 3.96 4.41" 4.58a 4.67a 457a 3.l8" 2.70"
liter/minim2 body surface ± 0.42 ± 0.45 ± 0.54 ± 0.65 ± 0.50 ± 0.33 ± 0.62
Stroke volume index, 49.0 51.0 50.0 50.0 47.0 33.0"' 29.0
mi/rn2 body surface ± 5.6 ± 5.4 ± 6.2 ± 6.5 ± 4.9 ± 3.0 ± 6.4
Total peripheral vascular 30.0 26.Oa 24.6" 23.5" 23.9" 33.1" 42.9
resistance index, U ± 5.1 ± 4.4 ± 4.5 ± 4.9 ± 3.8 ± 5.0 ± 9.0
a 0.01 <P < 0.05; b00Q1 < P < 0.01; cp < 0.001 by paired t test, comparing the values with recirculation-l values.
d 0.01 < P < 0.05; e 0.001 < P < 0.01; P < 0.001 by paired t test, comparing the values with recirculation-2 values.
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—40
Fig. 1. Changes in mean arterial pressure (L\MAP) during ultra-
filtration and dialysis separated in time. Comparisons were made
with values obtained during the preceding recirculation period.
Ultrafiltration followed by dialysis (procedure 1) is denoted by
closed circles (S). Dialysis followed by ultrafiltration (procedure
2) is denoted by open circles (0).
Ultrafiltration Dialysis
30mm 60mm 60mm 120mm 180mm
Fig. 3. Changes in cardiac index (zCI) during ultrafiltration and
dialysis separated in time. Ultrafiltration followed by dialysis
(procedure 1) is denoted by closed circles (•). Dialysis followed
by ultrafiltration (procedure 2) is denoted by open circles (0).
the initial recirculation period due to hemodilution.
In procedure 1, ultrafiltration induced a significant
increase in hematocrit and plasma protein, which
remained increased after dialysis. In procedure 2,
hematocrit and plasma protein were unchanged af-
ter dialysis and increased after ultrafiltration.
Discussion
The purpose of this investigation was to study the
hemodynamic mechanisms behind our earlier find-
ings that dialysis may induce hypotension even
without simultaneous ultrafiltration [4], whereas
rapid ultrafiltration, when performed alone, can be
tolerated without a fall in BP [3, 11]. We applied a
simple dye dilution technique for cardiac output de-
terminations, using the arteriovenous fistula. This
technique has been shown to give reliable results
-30
Fig. 2. Changes in heart rate (AHR) during ultrafiltration and
dialysis separated in time. Ultrafiltration followed by dialysis
(procedure 1) is denoted by closed circles (S). Dialysis followed
by ultrafiltration (procedure 2) is denoted by open circles (0).
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Fig. 4. Changes in stroke volume index (L.SVI) during ultra-
filtration and dialysis separated in time. Ultrafiltration followed
by dialysis (procedure 1) is denoted by closed circles (•).
Dialysis followed by ultrafiltration (procedure 2) is denoted by
open circles (0).
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compared with conventional dye dilution tech-
niques (that is, injection of dye into a central vein
and sampling from the brachial artery [13]). Cole-
man and Bower [16] demonstrated in dogs, with
shunt flows between 100 and 200 mllmin, that car-
diac output determination, using a shunt, have a
reasonably good accuracy compared with the con-
ventional technique. In our study, the blood flow
through the dialyzer was kept around 200 mI/mm,
which should be adequate when determining car-
diac output.
The results demonstrate that ultrafiltration alone
induces a marked decrease in cardiac output, main-
ly due to a decrease in stroke volume, probably re-
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Ultrafiltration
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Fig. 6. Changes in plasma renin activity after initial ultrafiltra-
tion for 60 mm (procedure 1), and after initial dialysis for 180
mm (procedure 2).
Table 4. Blood and plasma values in seven patients during procedures I and 2 (mean SEM)a
Procedure 1 Procedure 2
Start RC D 180 mm UFStart RC UF D 180 mm
pH
Osmolality,
mOsm/kg
Ureab,
mmoles/liter
7.39 7.39 7.42
0.03 0.03
286.0 286.0 285.0
6.8 7.5
____________**
28.54 28.20 28.20
2.47 2.37
***
7.44
271.0
13.55
I
7.41 7.40
±0.02
286.0 283.0
I
7.46
276.0
7.48
275.0
14.3326.70 27.62
I
**
13.96
I
Potassium5,
mmoles/liter
5.43 5.41 5.52
0.39 0.37
4.02 4.97 5.07 4.03 4.05
*1* a
Sodium5,
mmoles/liter
Bicarbonate",
mmoles/liter
Hematocnt, %
137.0 137.0 137.0
1.1 1.2
22.1 22.9 22.8
1.3 1.!
19.0 16.9 19.6
1.5 2.1
L__ * ___IL_______ I________* *
138.0
22.9
19.6
137.0 139.0
22.9 22.7
±0.5
18.6 17.6
±1.4
L.................. *
139.0
22.6
17.4
138.0
24.8
20.4
I
Total plasma
protein, g/liter
PRA, nglmllhr
63.8 58.7 71.0
1.4 4.2
I * I I * II________ *
10.8 13.5
11.1
67.8
I
18.5
16.1
64.3 57.8
10.6
63.4
8.4
72.6
9.4
aAbbrevjatiofls are: RC, recirculation; UF, ultrafiltration; D, dialysis.
"This is expressed per liter of plasma Water, which was calculated from total protein concentration, as previously described [II].
* 0.01 <P < 0.05 ** 0.001 < P < 0.01 p < 0.001 by paired t test, comparing the values with recirculation-1 values
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Fig. 5. Changes in total peripheral vascular resistance index
(ATPVRI) during ultrafiltration and dialysis separated in time.
Ultrafiltration followed by dialysis (procedure 1) is denoted by
closed circles (S). Dialysis followed by ultrafiltration (pro-
cedure 2) is denoted by open circles (0).
lated to the diminishing plasma volume leading to
decreasing venous return. BP was maintained fairly
constant, in most cases due to a marked increase in
peripheral vascular resistance.
S
.
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Similar hemodynamic changes were observed in
normal subjects, when the venous return was de-
creased by changing body position from the supine
to the upright [17], or by pooling of the blood to the
lower part of the body by means of low body nega-
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tive pressure stimulation (LBNP) [18]. During these
procedures, however, the decrease in stroke vol-
ume was partly compensated for by an increase in
heart rate. The lack of increase or even decrease in
heart rate during ultrafiltration in some of the pa-
tients in the present study may possibly be due to
autonomic insufficiency, known to be a sequel of
uremia [19—21].
Dialysis without simultaneous ultrafiltration, on
the other hand, induces a significant decrease in to-
tal peripheral vascular resistance and an increase in
cardiac output mainly due to an increase in heart
rate.
As shown in Fig. 7, the decrease in total peripher-
al vascular resistance index was associated with a
fall in BP in some of the patients. In other patients
BP remained stable, indicating that the increase in
cardiac output could compensate for the vasodila-
tory effect of dialysis.
It should be pointed out that the mean age was
high (55 years) and that no less than four of the sev-
en patients had cardiac impairment requiring treat-
ment with digoxin. Peripheral vasodilation, how-
ever, occurred in all patients and was not related to
age nor to cardiac status.
Azancot et al [7] have demonstrated a decrease in
heart rate, cardiac index, and stroke volume index
during hypotensive episodes in conventional dial-
ysis (ultrafiltration + dialysis), that is, similar
changes as found by us during ultrafiltration alone.
There was, however, no significant change in total
peripheral vascular resistance. This supports the
conclusion that dialysis interferes with the normal
increase in total peripheral vascular resistance in-
duced by hypovolemic stimuli.
Rouby et al [22] and Hampi et al [23] also ob-
served a decrease in cardiac index and an increase
in total peripheral vascular resistance during ultra-
filtration, whereas during dialysis cardiac index in-
creased and total peripheral vascular resistance de-
creased. In these studies, however, ultrafiltration
could not be completely avoided during dialysis.
The reason why the peripheral resistance, which
increases during ultrafiltration, decreases during
dialysis is far from clear. It has been suggested that
a rapid decrease in osmolality may play a role in the
development of dialysis-associated hypotension [3,
11, 24] possibly by affecting the vascular vasorecep-
tors or autonomic nerves. Severe hypotension dur-
ing dialysis has been related to autonomic neuropa-
thy [21, 25], which appears to affect the afferent
limb of the baroreceptor reflex arc [26]. It was re-
ported recently that plasma noradrenaline concen-
tration increases during ultrafiltration but falls or is
unchanged during dialysis, suggesting that relative
depletion of circulating noradrenaline by dialysis
might cause or contribute to vascular instability
during dialysis [27, 28]. Acetate is known to give
vasodilation [29], and acetate in the dialysate has
been reported to contribute to cardiovascular insta-
bility during dialysis [32].
The increase in PRA during ultrafiltration is pre-
sumably related to hypovolemia, known to be a po-
tent stimulus for renin secretion [33]. Increased pe-
ripheral vascular resistance during ultrafiltration
was also observed in the binephrectomized patient
of this study, indicating that the vasocontrictive re-
sponse was not depending on renin-angiotensin
stimulation. We found a fall in PRA after dialysis
alone, whereas Henrich et al [34] found an increase
in PRA during combined dialysis and ultrafiltration.
Hence, in conventional dialysis, the stimulating ef-
fect of hypovolemia on PRA seems to predominate
over the effect of dialysis alone.
The hemodynamic response to dialysis (vasodila-
tion, increase in cardiac output and heart rate) is
similar to the effect of antihypertensive agents, such
as hydralazine, which exert a direct dilatory effect
on arteriolar muscle walls. One important dif-
ference, however, is that dialysis induces a slight
decrease in PRA, whereas hydralazine increases
PRA, probably secondarily to reflexogenic sympa-
thetic stimulation [35].
On the other hand, peripheral vasodilation by
means of peripheral a-adrenoreceptor blockade
with prazosin tends to decrease PRA [36]. Our find-
ing that PRA decreases during dialysis would sup-
port the conclusion that the vasodilation during
dialysis is at least partly due to decreased peripheral
sympathetic vasoconstrictor activity. A direct vaso-
dilatory effect of dialysis, however, can not be ex-
cluded.
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Fig. 7. Changes in mean arterial pressure (AMAP) and totalpe-
ripheral vascular resistance index (ATPVRI) during dialysis
(procedure 2).
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